Zoetis Jumps 20% In Debut by Chris Dieterich and Peter Loftus. The Wall Street Journal. February 1, 2013.
Zoetis, the former animal health unit of Pfizer, is now a new, separate company worth $15 billion. Illustrating the interrelationship of human and animal health, the growth of the global middle class has spurred the global demand for animal protein sources. In that light and in the face of limited water and land, the animal drug products that promoted productivity in producing protein are attractive. However some countries have introduced bans on antibiotics in food-producing animals.
No comments:
Post a Comment